Our lab hosted the Research Nexus Program symposium featuring Dr. Faisal Mahmood from Harvard Medical School as the keynote speaker. The event, titled "Pixels to Precision Medicine: At the Intersection of AI and Pathology," brought together leading researchers in computational pathology and medical AI. Dr. Mahmood shared insights from his pioneering work published in Nature Medicine, Cancer Cell, and top-tier AI conferences including CVPR and NeurIPS. The symposium fostered valuable discussions on the integration of artificial intelligence in pathological diagnosis and precision medicine, strengthening collaborative ties between Korean and international research communities in computational pathology.

Before delivering his keynote lecture at Korea University Medical School, Dr. Faisal Mahmood explored Seoul's iconic landmarks and cultural treasures.

PathFinder Lab successfully organized the REG 2025 (REport Generation in pathology using Pan-Asia Giga-pixel WSIs) challenge during MICCAI 2025 in Daejeon. The challenge focused on advancing automatic pathology report generation by tasking participants to convert gigapixel whole-slide images into clinically sound diagnostic text reports.

From September 23–27, 2025, PathFinder Lab attended MICCAI 2025 in Daejeon, Korea. The conference provided exposure to leading research in medical image computing and computer-assisted intervention. The lab organized the REG challenge on Saturday. Key highlights included productive sessions with computational pathology groups and collaborative discussions with international teams. The visit served as an opportunity for lab membership training and professional development sessions. The week concluded with a lab dinner, fostering team bonding and celebrating successful conference participation.

Our lab got together for a group photo followed by a lunch outing. It was a great chance to capture where we are as a team and to enjoy some time outside the lab over good food and conversation. Spending time together like this helps us stay connected and motivated as we continue our work.

From June 11–15, 2025, PathFinder Lab members Sangjeong Ahn and Hyeseong Lee attended CVPR 2025 in Nashville, TN. With over 2,800 accepted papers, the event provided exposure to leading research in medical AI and foundation models. Key highlights included sessions with Kather Lab, Faisal Mahmood Lab, Paige, and new collaborations with Stony Brook University. The visit strengthened academic ties and inspired new directions in pathology image restoration.

From April 25–30, 2025, three members of the PathFinder Lab attended the AACR Annual Meeting in Chicago. Moonyoung Lee and Harim Chun presented research posters, while the team engaged with sessions focused on spatial omics, AI-driven pathology, and therapeutic targeting. The conference offered valuable perspectives on computational cancer biology and biomarker discovery. These insights directly inform and strengthen the lab’s current research directions.

2nd PathFinder Lab Workshop was held February 6-7 at Vivaldi Park in Hongcheon, combining skiing with scientific presentations on pathology image analysis, deep learning, and genomics data analysis. This blend of winter sports, research presentations, and social activities successfully advanced interdisciplinary projects while strengthening team collaboration.

REG 2025 pushes automatic pathology report generation by tasking participants to convert Pan-Asia gigapixel whole-slide images into clinically sound text. A 20,500-case dataset from six centers is provided; pretrained weights permitted, extra data barred; schedule extended amid server fixes.

Pathfinder Lab has been at the forefront of developing AI-powered software for analyzing digital pathology images, with a particular focus on cancer detection. Pathfinder Lab has been at the forefront of developing AI-powered software for analyzing digital pathology images.

Our strength lies in our partnerships. By collaborating with leading university hospitals, such as the University Hospital Zurich and Women’s Hospital, we’ve built a robust network that combines academic expertise with clinical insights.

One of our core goals is to democratize access to advanced diagnostic tools. We’re proud to announce that our software has been adopted by over 50 mid-sized hospitals across North America and Europe, enabling them to provide high-quality pathology services without the need for in-house expertise. Additionally, we’ve partnered with government health agencies in Canada and the UK to integrate our AI-driven diagnostics into national healthcare systems, improving diagnostic accuracy for unders

We’re excited to continue sharing our work with the global pathology community. Next month, Pathfinder Lab will be presenting at the International Conference on Medical Image Computing and Computer-Assisted Intervention (MICCAI) 2025, where we’ll introduce a new computational framework for kidney transplant outcome prediction.A

As we continue to innovate, our slogan—“Pioneering the Field of Digital Pathology with Challenge and Expertise”—remains at the heart of everything we do.